Sunact Cancer Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.23 M
- Company Age 1 Year 5 Months
- Last Filing with ROC 31 Mar 2024
About Sunact Cancer Institute
Sunact Cancer Institute Private Limited (SCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2023 (One year and five months 17 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.23 M, as per Ministry of Corporate Affairs (MCA) records.
Ashay Karpe and Patil Maruti serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U86100MH2023PTC409378
-
Company No.
409378
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Who are the key members and board of directors at Sunact Cancer Institute?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashay Karpe
|
Director | 30-Nov-2023 | Current |
|
Patil Maruti
|
Additional Director | 30-Nov-2023 | Current |
Financial Performance of Sunact Cancer Institute.
Enhance accessibility to Sunact Cancer Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunact Cancer Institute?
Unlock access to Sunact Cancer Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Shree Saisamarth Healthcare Private LimitedAshay Karpe and Patil Maruti are mutual person
-
Midas Lifecare International Private Limited
Ashay Karpe is a mutual person
-
Dashakantha Onco Care Private Limited
Patil Maruti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunact Cancer Institute?
Unlock and access historical data on people associated with Sunact Cancer Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunact Cancer Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunact Cancer Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
